ANI Pharmaceuticals Inc (ANIP) Annual Income Statement (USD)
ANIP Quarterly Financials (USD)
Frequently Asked Questions About ANI Pharmaceuticals Inc (ANIP) Stock
ANI Pharmaceuticals Inc's (ANIP) last reported annual revenue was USD 486.82 Million.
ANI Pharmaceuticals Inc's (ANIP) annual revenue growth rate based on the revenue reported in the past 5 years is : 19.28%
ANI Pharmaceuticals Inc's(ANIP) is profitable as of its last reported annual financials.
The net profit margin for ANI Pharmaceuticals Inc's(ANIP) from its laster reported year is 3.86%
The return on equity (ROE) for ANI Pharmaceuticals Inc's(ANIP) from its last reported annual financials is : -1.60%
The return on assets (ROA) for ANI Pharmaceuticals Inc's(ANIP) from its last reported annual financials is : 1.25%
The return on invested capital (ROIC) for ANI Pharmaceuticals Inc's(ANIP) from its last reported annual financials is : 6.83%
The Debt to Equity ratio for ANI Pharmaceuticals Inc's(ANIP) from its last reported annual financials is : 65.82%
The dividend yield for ANI Pharmaceuticals Inc's(ANIP) from its laster reported year is 0.00%
ANI Pharmaceuticals Inc's(ANIP) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ANIP !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
